Skip to content

Electroacupuncture of different treatment frequency on pregnancy outcome of IVF/ICSI in infertile patients: a pilot randomized controlled trial

Electroacupuncture of different treatment frequency on pregnancy outcome of IVF/ICSI in infertile patients: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082888
Enrollment
Unknown
Registered
2024-04-10
Start date
2024-04-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Electroacupuncture low frequency therapy + IVF group:Electroacupuncture low frequency therapy+ Conventional IVF therapy
Electroacupuncture high frequency therapy + IVF group:Electroacupuncture high frequency therapy+ Conventional IVF therapy
IVF group:Conventional IVF therapy

Sponsors

Sichuan Jinxin Xi'nan Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 42 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for infertility: 1 couple is not using contraception and has had regular sexual intercourse for at least 12 months without achieving a clinical pregnancy (Consensus on Infertility by American Experts 2021). (2) Those who plan to use IVF-ET (ovulation induction regimen is GnRH-a long regimen or antagonist). (3) Women of childbearing age: 21 = age 1.2ng/ml. (6) Previous IVF = 2 times. (7) Did not participate in other ongoing clinical studies and did not receive acupuncture treatment for infertility in the past 3 months. (8) Agree to receive acupuncture adjuvant therapy during the period of routine IVF-ET promotion, and the informed consent form shall be signed by the patient himself or by his immediate family members. Note: only patients who meet the above 8 items can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Pre-implantation embryo genetic testing (PGT). (2) The patient has uterine malformations (untreated uterus, biangular uterus, biangular uterus or untreated uterine septum) or other untreated diseases that can damage the endometrial cavity, such as adenomyosis, submucous myoma, uterine adhesion or scar uterus. (3) Complicated with metabolic endocrine diseases such as uncorrected hyperprolactinemia, hyperandrogenemia, thyroid dysfunction, chronic adrenocortical dysfunction and so on. (4) Diagnosis of polycystic ovary syndrome, repeated implantation failures, recurrent miscarriages; (5) The male partner is diagnosed with severe hypospermia, hypospermia, or abnormality of spermatozoa; (6) Those who have bleeding tendency and those who are prone to infection, or those who have severe allergies, or those who have skin ulcers or scarring that prohibit needling. Note: Patients who meet any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
Blastula rate;Patient intervention completion rate;

Secondary

MeasureTime frame
Number of eggs received;Number of embryos;Patient treatment adherence;

Countries

China

Contacts

Public ContactJie Yang

Chengdu University of Traditional Chinese Medicine; Sichuan Jinxin Xi'nan Women's and Children's Hospital

jenny_yang_jie@126.com+86 138 8229 6714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026